Key facts
- Shoulder Innovations (NYS: SI)’s last known valuation is $303.4M (Jul 2025).
- It has raised $231.2M; the latest was IPO ($75.0M) in Jul 2025.
- Notable investors include Gilde Healthcare, Trinity Capital Inc BDC, Cultivate(MD), U.S. Venture Partners.
- 4 institutional filers report fund marks on Shoulder Innovations (NYS: SI) across 40 filings.
- Status: Publicly Held.
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for Shoulder Innovations (NYS: SI)
- ·The full record, as it builds
Funding rounds
No funding rounds for Shoulder Innovations (NYS: SI) are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Shoulder Innovations (NYS: SI)
Shoulder Innovations Inc is a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market. It currently offers advanced implant systems for shoulder arthroplasty. Its products include: InSet Total Shoulder Arthroplasty; InSet Reverse Shoulder Arthroplasty; ProVoyance Shoulder Planning Software; and InSet Tray System. Geographically, the company operates in United States and are planning to expand.
- Sector
- Healthcare
- HQ
- Holland, MI, United States
- Founded
- 2009
- Employees
- 75
- Website
- shoulderinnovations.com/
- Ownership
- Publicly Held
Shoulder Innovations (NYS: SI) doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Shoulder Innovations (NYS: SI) shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
4 filers · latest Jun 20264 SEC-registered funds reported 40 fair-value marks on Shoulder Innovations (NYS: SI) between Jul 2025 and Jun 2026. Filer-level marks and implied $/share are available to Pro members.